Cost-benefit relationship of keeping dantrolene stocks from the point of view of healthcare institutions
Rev. colomb. anestesiol; 48 (2), 2020
Abstract Introduction: Malignant hyperthermia (MH) is an acute syndrome triggered by certain anesthetic medications. Dantrolene is the only specific treatment for MH crises. Without treatment, lethality may be as high as 80%. In Colombia, it is not mandatory to keep dantrolene supplies in stock. Object...